课题基金 / 基金详情

Targeting Cancer Drug Resistance: Bioflavonoid-Stimulated Glutathione Efflux by Multidrug Resistance Protein 1

Targeting Cancer Drug Resistance: Bioflavonoid-Stimulated Glutathione Efflux by Multidrug Resistance Protein 1
靶向癌症耐药性：生物类黄酮通过多药耐药性蛋白 1 刺激谷胱甘肽流出
批准号：
331417
负责人：
Millott Robyn A
金额：
$1.27万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-12-01 至 2015-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=331417&lang=en
关键词：
Cancer Drug Resistance Drug Transport Experimental Medicine Membrane Protein Biochemistry Natural Products

项目摘要

项目成果

Millott Robyn A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer is among the leading causes of death worldwide. Roughly 40% of Canadians will be diagnosed with the disease during their lifetime, based on a 2009 projection by the Canadian Cancer Society. Although tools have been developed to fight cancer very ef
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Regulation of p53 Through Site-Specific Dephosphorylation
  • 批准号：
    350110
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2015
  • 负责人：
    Millott Robyn A
  • 依托单位：
    University of Alberta
海外基金